SPARCL1 and Mental deterioration: In conclusion, we provide a proof of concept that by increasing astrocytic Hevin levels in the hippocampus, we abrogate cognitive decline both in pathological and normal aging highlighting Hevin as a potential novel intervention for age‐associated cognitive decline.